Imaging and Clinical Data Distinguish Lymphadenopathy-First-Presenting Kawasaki Disease from Bacterial Cervical

Byung Sung Park1, Myung Hoon Bang1, Sung Hye Kim1

  • 1Department of Pediatrics, Hallym University Sacred Heart Hospital, Anyang, Korea.

Insights

Lymphadenopathy-first-presenting Kawasaki disease (LKD) can mimic bacterial cervical lymphadenitis (BCL). Differentiating LKD involves assessing CT for abscesses, patient age, and C-reactive protein (CRP) levels.

Area of Science:

  • Pediatric Infectious Diseases
  • Diagnostic Imaging
  • Rheumatology

Background:

  • Kawasaki disease (KD) can initially present with fever and cervical lymphadenopathy, mimicking bacterial cervical lymphadenitis (BCL).
  • This presentation, termed lymphadenopathy-first-presenting Kawasaki disease (LKD), poses diagnostic challenges.
  • Early differentiation is crucial for appropriate management and preventing complications.

Purpose of the Study:

  • To identify characteristic imaging and clinical features that distinguish LKD from BCL.
  • To compare diagnostic markers between LKD and BCL patients.

Main Methods:

  • A retrospective study comparing imaging, clinical, and laboratory data of patients with LKD, BCL, and typical KD.
  • Inclusion criteria: patients admitted to a single tertiary center between January 2015 and July 2018.
  • Multivariable logistic regression analysis was used to identify independent predictors.

Main Results:

  • Ultrasound showed enlarged lymph nodes in both LKD and BCL; CT revealed more abscesses in BCL.
  • LKD patients were younger and exhibited higher systemic/hepatobiliary inflammatory markers and pyuria than BCL patients.
  • Younger age and elevated C-reactive protein (CRP) were independently associated with LKD. No increased coronary artery abnormalities (CAA) in LKD vs. typical KD.

Conclusions:

  • Absence of CT abscesses, younger age, and elevated CRP are key differentiators for LKD versus BCL.
  • LKD patients show increased systemic inflammation and pyuria compared to BCL.
  • LKD does not confer a higher risk of coronary artery abnormalities compared to typical KD.
Abstract

Related Concept Videos

Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.5K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
646
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
369
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
939
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
581
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
425